Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2017-09-13
Summary
Purpose of the study is to determine transcriptomics, metabolomics and proteomics features of liver cirrhotic tissue in patients with hepatocellular carcinoma (HCC) and to find a correlation with the risk of developing HCC and survival.
Conditions
- Carcinoma, Hepatocellular
Sponsors & Collaborators
-
University of Modena and Reggio Emilia
lead OTHER
Principal Investigators
-
ERICA VILLA · Università di Modena e Reggio Emilia
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2017-12-31
- Completion
- 2018-12-31
Countries
- Italy
Study Locations
More Related Trials
-
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
NCT03804593 ·Status: COMPLETED
-
Evaluation of Risk of hEpatocellular Carcinoma
NCT06523179 ·Status: RECRUITING ·Phase: NA
-
Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease
NCT06871930 ·Status: NOT_YET_RECRUITING
-
Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease
NCT03307408 ·Status: UNKNOWN
-
Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
NCT01798173 ·Status: COMPLETED ·Phase: NA
-
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
NCT05623150 ·Status: RECRUITING
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis
NCT06778317 ·Status: NOT_YET_RECRUITING
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Harms of Hepatocellular Carcinoma Surveillance
NCT03756051 ·Status: COMPLETED
-
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
NCT04076631 ·Status: UNKNOWN
-
Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
NCT06777914 ·Status: RECRUITING
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma
NCT07272200 ·Status: RECRUITING ·Phase: NA
-
Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis
NCT03318380 ·Status: COMPLETED ·Phase: NA
-
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335 ·Status: RECRUITING
-
Prognostic Models for HCC Based on Tumor Micronecrosis
NCT05837065 ·Status: UNKNOWN
-
Hepatocellular Carcinoma Growth and Molecular Aggressiveness
NCT01657695 ·Status: COMPLETED
-
Epidemiologic Study of Hepatocellular Carcinoma in the US
NCT02358070 ·Status: COMPLETED
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07275554 ·Status: RECRUITING
-
HCC Innervation Assessment
NCT06886763 ·Status: ACTIVE_NOT_RECRUITING
-
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
NCT02074202 ·Status: UNKNOWN ·Phase: PHASE3
-
Metabolic Syndrome and Long-term Survival Following Liver Resection
NCT05568576 ·Status: COMPLETED
-
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
NCT01825213 ·Status: COMPLETED